Breast Cancer: The Need for Axillary Clearances Can Be Significantly Reduced

In this MEDtalk, Marie-Jeanne Vrancken Peeters discusses tailored axillary treatments in patients with breast cancer who are treated with primary surgery first. She emphasizes that due to the effectiveness of systemic treatment, especially for triple-negative and HER2-positive diseases, the need for axillary clearances can be significantly reduced.